
Spotlight on Abzena’s Developability Platform
Spotlight on Abzena’s Developability Platform during Antibody Engineering & Therapeutics 2019. New service reduces the risk, expenditure and time required for the later stages of antibody development Abzena is showcasing its new Developability Service, enabling biotechnology and pharmaceutical companies to improve lead selection and… Read More















